Platelet Transfusions for Medication Reversal

Severity-Based Approach to Platelet Transfusion

The American Academy of Otolaryngology-Head and Neck Surgery recommends platelet transfusions to reverse platelet inhibitor medications, including aspirin, clopidogrel, prasugrel, ticagrelor, and ticlopidine, but only in the context of severe or life-threatening bleeding, not for non-severe bleeding that can be controlled with local measures 1, 2, 3
Platelet transfusion is indicated when one or more of the following apply: posterior nosebleed with hemodynamic instability, hemoglobin decrease ≥ 2 g/dL, requirement for ≥ 2 units of RBCs, or intracranial hemorrhage or other critical organ bleeding 1, 2, 4

The American Academy of Otolaryngology-Head and Neck Surgery recommends reversing the following medications with platelet transfusion: aspirin, clopidogrel, ticagrelor, and ticlopidine 1, 2, 3, 4, 5
Warfarin, heparin/LMWH, and DOACs are not reversed with platelet transfusion, but rather with fresh frozen plasma, 4-factor PCC, or vitamin K, protamine sulfate, or 4-factor PCC or idarucizumab, respectively 1, 2

The recommended platelet dosing is 5 units for aspirin alone, 10-15 units for aspirin plus clopidogrel combination, and 10-15 units for clopidogrel alone 4, 6
Platelet transfusion may not be effective depending on the timing of the most recent dose of medication, and for clopidogrel, it is recommended to wait at least 6 hours after the last dose before transfusing platelets 1, 2, 3, 4

The evidence for platelet transfusion effectiveness varies significantly by medication, and platelet transfusion is effective for aspirin reversal but does not effectively restore platelet function in patients taking clopidogrel 4, 5
Meta-analyses of traumatic intracranial hemorrhage patients on antiplatelet agents have failed to show survival benefit from platelet transfusion, and some studies suggest increased mortality 5, 6

Desmopressin may be used to support hemostasis in patients on platelet inhibitors, though it does not reverse the platelet inhibitory effects, and its efficacy for clopidogrel reversal is "very uncertain" 1, 2, 4, 7
Antifibrinolytics, such as tranexamic acid and aminocaproic acid, may support hemostasis but do not reverse platelet inhibitory effects 1, 2, 7
Recombinant Factor VIIa should not be used as first-line reversal due to increased thromboembolic risk, especially in elderly patients 4, 7

Assess bleeding severity using the criteria above, and for non-severe bleeding, withhold next dose of antiplatelet medication, apply local hemostatic measures first, and do not transfuse platelets 1, 2
For severe/life-threatening bleeding, discontinue antiplatelet medication immediately, initiate local measures simultaneously, administer platelet transfusion at appropriate dose based on medication, and consider desmopressin as adjunctive therapy 1, 2, 4, 6, 7